9/9/2025China's NMPA Seeks Public Feedback on Draft Guidelines for Online Pres...

9/8/2025Epigenic Secures $60M in Series B Financing to Advance Epigenetic Drug...

9/8/2025Avadel Partners with XWPharma to Advance Valiloxybate for Sleep Disord...

9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...

9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...

9/8/2025Innovent's Tigulixostat Demonstrates Superior Efficacy in Phase 2 Gout...

9/8/2025Junshi Achieves Positive Phase 3 Results for JS005 in Psoriasis Treatm...

9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...

9/8/2025CDE Issues Technical Guidelines for Clinical Pharmacology Research on ...

9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...

9/8/2025CDE Issues Guidance on Evaluating pH-Dependent Drug Interactions for O...

9/8/2025CDE Seeks Comments on Draft Technical Guidelines for Chemically Synthe...

9/8/2025CDE Opens Public Consultation on Draft Guidelines for Type I Meetings ...

9/8/2025CDE Solicits Comments on Draft Guidelines for Type I Meetings on Advan...

9/8/2025CDE Seeks Comments on Draft Guidelines for Clinical Trials of Anti-Fib...

9/8/2025CDE Invites Feedback on Draft Guidelines for Clinical Trials of Target...

9/8/2025CDE Opens Public Consultation on Draft Guidelines for Clinical Trials ...

9/8/2025NHSA Seeks Feedback on Draft Implementation Rules for Medical Insuranc...

9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...

9/5/20253SBio Secures IND Nod for Dual-Target CAR-T Therapy SA102

9/5/2025Yangtze River's Fexuprazan Gains Chinese Approval

9/5/2025Hengrui Licenses Myosin Inhibitor HRS-1893 to U.S. Startup Braveheart ...

9/5/2025How China Seeks to Solve Its Quality Control Conundrum (C&EN)

9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...

9/4/2025iRegene Raises Series B+ to Advance Parkinson's and Ophthalmology Cell...

9/4/2025CDE Seeks Comments on Draft Guidelines for Pan-Cancer Drug Development

9/3/2025Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...

9/3/2025China Biopharma Sees $320M Upfronts and $8.5B Milestones in H1 2025 Li...

9/3/2025Argo Biopharma Strikes $5.2B Cardiovascular Collaboration with Novarti...

9/3/2025Sanofi China Receives Approval for Tzield to Delay Progression of Type...

Page:2/789 Total number of articles:23668: [First][<<] [1] [2] [3] [4] [5] [>>] [End]